PDF(Pubmed)
Abstract：
UNASSIGNED: Intravenous (IV) infusion therapy is commonly used in health care settings. However, IV therapy at home can be challenging because it relies on the patient\'s ability to manage multiple medications correctly, which may lead to decreased treatment adherence.
UNASSIGNED: We aimed to assess the usability and accuracy of the IVsight monitor in capturing IV infusion data compared to manual recording.
UNASSIGNED: A prospective, single-center, usability study involving patients receiving IV infusion therapy at one of the BJC\'s Home Infusion suites was conducted to evaluate the accuracy, performance, and acceptability of the device IVsight as a monitor for IV infusions.
UNASSIGNED: Of the 15 participants, the median (IQR) age was 46 years (36-55), 8 (53%) were female, and 13 (87%) were non-Hispanic white. Each participant received a median (IQR) of 4 (4-5) infusions during the study, and 68 infusions were observed overall. The intraclass correlation coefficient between the IVsight measurement and manual recording of infusion duration in seconds was excellent (ICC 0.97, 95% confidence interval 0.96-0.98). The Bland-Altman plot visually showed an acceptable limit of agreement for the 2 measurements, and the linear regression analysis revealed no significant proportional bias between the 2 methods for measuring the IV infusion time. None of the participants thought that IVsight was difficult to hold, use, clean, or store. Only one participant was concerned that the device could interfere with the IV infusion, and all participants felt comfortable with the device transmitting data to their health care providers.
UNASSIGNED: The IVsight infusion monitoring device showed near-perfect agreement on the recorded IV infusion duration compared with manual recording, and good acceptability among the study participants.
UNASSIGNED: We aimed to assess the usability and accuracy of the IVsight monitor in capturing IV infusion data compared to manual recording.
UNASSIGNED: A prospective, single-center, usability study involving patients receiving IV infusion therapy at one of the BJC\'s Home Infusion suites was conducted to evaluate the accuracy, performance, and acceptability of the device IVsight as a monitor for IV infusions.
UNASSIGNED: Of the 15 participants, the median (IQR) age was 46 years (36-55), 8 (53%) were female, and 13 (87%) were non-Hispanic white. Each participant received a median (IQR) of 4 (4-5) infusions during the study, and 68 infusions were observed overall. The intraclass correlation coefficient between the IVsight measurement and manual recording of infusion duration in seconds was excellent (ICC 0.97, 95% confidence interval 0.96-0.98). The Bland-Altman plot visually showed an acceptable limit of agreement for the 2 measurements, and the linear regression analysis revealed no significant proportional bias between the 2 methods for measuring the IV infusion time. None of the participants thought that IVsight was difficult to hold, use, clean, or store. Only one participant was concerned that the device could interfere with the IV infusion, and all participants felt comfortable with the device transmitting data to their health care providers.
UNASSIGNED: The IVsight infusion monitoring device showed near-perfect agreement on the recorded IV infusion duration compared with manual recording, and good acceptability among the study participants.
摘要：
■静脉（IV）输注疗法通常用于医疗保健机构。然而,在家中进行IV治疗可能具有挑战性，因为它依赖于患者正确管理多种药物的能力，这可能导致治疗依从性下降。
■我们旨在评估与手动记录相比，IVsight监护仪在捕获IV输注数据方面的可用性和准确性。
■预期，单中心,在BJC的家庭输液套件之一接受静脉输液治疗的患者进行可用性研究，以评估准确性，性能，以及IVsight设备作为静脉输液监测器的可接受性。
■在15名参与者中，中位年龄（IQR）为46岁（36-55岁），8人（53%）为女性，和13（87％）是非西班牙裔白人。每位参与者在研究期间接受了4（4-5）次输注的中位数（IQR），总共观察到68次输液。IVsight测量与手动记录输注持续时间(秒)之间的组内相关系数非常好(ICC为0.97,95%置信区间为0.96-0.98)。Bland-Altman图在视觉上显示了2次测量的可接受的一致性极限，线性回归分析显示，两种方法测量静脉输液时间之间没有明显的比例偏差。没有一个参与者认为IVsight很难持有，使用,干净,或商店。只有一名参与者担心该装置会干扰静脉输液，所有参与者都对将数据传输给医疗保健提供者的设备感到满意。
■与手动记录相比，IVsight输液监测装置在记录的IV输液持续时间上显示出近乎完美的一致性，以及研究参与者的良好接受度。
■我们旨在评估与手动记录相比，IVsight监护仪在捕获IV输注数据方面的可用性和准确性。
■预期，单中心,在BJC的家庭输液套件之一接受静脉输液治疗的患者进行可用性研究，以评估准确性，性能，以及IVsight设备作为静脉输液监测器的可接受性。
■在15名参与者中，中位年龄（IQR）为46岁（36-55岁），8人（53%）为女性，和13（87％）是非西班牙裔白人。每位参与者在研究期间接受了4（4-5）次输注的中位数（IQR），总共观察到68次输液。IVsight测量与手动记录输注持续时间(秒)之间的组内相关系数非常好(ICC为0.97,95%置信区间为0.96-0.98)。Bland-Altman图在视觉上显示了2次测量的可接受的一致性极限，线性回归分析显示，两种方法测量静脉输液时间之间没有明显的比例偏差。没有一个参与者认为IVsight很难持有，使用,干净,或商店。只有一名参与者担心该装置会干扰静脉输液，所有参与者都对将数据传输给医疗保健提供者的设备感到满意。
■与手动记录相比，IVsight输液监测装置在记录的IV输液持续时间上显示出近乎完美的一致性，以及研究参与者的良好接受度。
